Literature DB >> 28112022

Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes.

Sarah Al-Bachari1,2,3, Rishma Vidyasagar2,4,5, Hedley Ca Emsley6,7, Laura M Parkes2,8.   

Abstract

Neurovascular changes are likely to interact importantly with the neurodegenerative process in idiopathic Parkinson's disease (IPD). Markers of neurovascular status (NVS) include white matter lesion (WML) burden and arterial spin labelling (ASL) measurements of cerebral blood flow (CBF) and arterial arrival time (AAT). We investigated NVS in IPD, including an analysis of IPD clinical phenotypes, by comparison with two control groups, one with a history of clinical cerebrovascular disease (CVD) (control positive, CP) and one without CVD (control negative, CN). Fifty-one patients with IPD (mean age 69.0 ± 7.7 years) (21 tremor dominant (TD), 24 postural instability and gait disorder (PIGD) and six intermediates), 18 CP (mean age 70.1 ± 8.0 years) and 34 CN subjects (mean age 67.4 ± 7.6 years) completed a 3T MRI scan protocol including T2-weighted fluid-attenuated inversion recovery (FLAIR) and ASL. IPD patients showed diffuse regions of significantly prolonged AAT, small regions of lower CBF and greater WML burden by comparison with CN subjects. TD patients showed lower WML volume by comparison with PIGD patients. These imaging data thus show altered NVS in IPD, with some evidence for IPD phenotype-specific differences.

Entities:  

Keywords:  Magnetic resonance imaging; Parkinson’s disease; arterial spin labelling; cerebral blood flow; cerebrovascular disease

Mesh:

Substances:

Year:  2017        PMID: 28112022      PMCID: PMC5624390          DOI: 10.1177/0271678X16688919

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  51 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

3.  Regional cerebral arterial transit time hemodynamics correlate with vascular risk factors and cognitive function in men with coronary artery disease.

Authors:  B J MacIntosh; W Swardfager; A D Robertson; E Tchistiakova; M Saleem; P I Oh; N Herrmann; B Stefanovic; K L Lanctôt
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-21       Impact factor: 3.825

4.  Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI.

Authors:  Koji Kamagata; Yumiko Motoi; Masaaki Hori; Michimasa Suzuki; Atsushi Nakanishi; Keigo Shimoji; Shinsuke Kyougoku; Ryohei Kuwatsuru; Keisuke Sasai; Osamu Abe; Yoshikuni Mizuno; Shigeki Aoki; Nobutaka Hattori
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

Review 5.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

6.  Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency.

Authors:  R R Edelman; B Siewert; D G Darby; V Thangaraj; A C Nobre; M M Mesulam; S Warach
Journal:  Radiology       Date:  1994-08       Impact factor: 11.105

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 8.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Authors:  Amy R Nelson; Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Biochim Biophys Acta       Date:  2015-12-17

9.  Multiple inflow pulsed arterial spin-labeling reveals delays in the arterial arrival time in minor stroke and transient ischemic attack.

Authors:  B J MacIntosh; A C Lindsay; I Kylintireas; W Kuker; M Günther; M D Robson; J Kennedy; R P Choudhury; P Jezzard
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-28       Impact factor: 3.825

10.  Increased CSF biomarkers of angiogenesis in Parkinson disease.

Authors:  Shorena Janelidze; Daniel Lindqvist; Veronica Francardo; Sara Hall; Henrik Zetterberg; Kaj Blennow; Charles H Adler; Thomas G Beach; Geidy E Serrano; Danielle van Westen; Elisabet Londos; M Angela Cenci; Oskar Hansson
Journal:  Neurology       Date:  2015-10-28       Impact factor: 9.910

View more
  18 in total

1.  GLP-1 receptor agonists for Parkinson's disease.

Authors:  Caroline A Mulvaney; Gonçalo S Duarte; Joel Handley; David Jw Evans; Suresh Menon; Richard Wyse; Hedley Ca Emsley
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23

2.  In vivo imaging and analysis of cerebrovascular hemodynamic responses and tissue oxygenation in the mouse brain.

Authors:  Kassandra Kisler; Divna Lazic; Melanie D Sweeney; Shane Plunkett; Mirna El Khatib; Sergei A Vinogradov; David A Boas; Sava Sakadži; Berislav V Zlokovic
Journal:  Nat Protoc       Date:  2018-05-24       Impact factor: 13.491

3.  Two-Photon Phosphorescence Lifetime Microscopy.

Authors:  Nastaran Abbasizadeh; Joel A Spencer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.

Authors:  Xueling Suo; Du Lei; Lan Cheng; Nannan Li; Panli Zuo; Danny J J Wang; Xiaoqi Huang; Su Lui; Graham J Kemp; Rong Peng; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2018-12-07       Impact factor: 5.038

5.  Age-related decline in circulating IGF-1 associates with impaired neurovascular coupling responses in older adults.

Authors:  Luca Toth; Andras Czigler; Emoke Hegedus; Hedvig Komaromy; Krisztina Amrein; Endre Czeiter; Andriy Yabluchanskiy; Akos Koller; Gergely Orsi; Gabor Perlaki; Attila Schwarcz; Andras Buki; Zoltan Ungvari; Peter J Toth
Journal:  Geroscience       Date:  2022-07-23       Impact factor: 7.581

Review 6.  GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.

Authors:  Giulia Monti; Diana Gomes Moreira; Mette Richner; Henricus Antonius Maria Mutsaers; Nelson Ferreira; Asad Jan
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

7.  Early disturbance of dynamic synchronization and neurovascular coupling in cognitively normal Parkinson's disease.

Authors:  Song'an Shang; Jing Ye; Jingtao Wu; Hongying Zhang; Weiqiang Dou; Vijaya Prakash Krishnan Muthaiah; Youyong Tian; Yingdong Zhang; Yu-Chen Chen; Xindao Yin
Journal:  J Cereb Blood Flow Metab       Date:  2022-04-26       Impact factor: 6.960

8.  [Voxel-based analysis of cerebral blood flow changes in Parkinson disease using arterial spin labeling technique].

Authors:  Rong Zhao; Tianzhong Wang; Zhengli Di; Junle Yang; Min Xu; Zhiqin Liu; Xurong Zhu; Xiaoping Wu; Xiaoyu Gao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

Review 9.  The role of brain vasculature in neurodegenerative disorders.

Authors:  Melanie D Sweeney; Kassandra Kisler; Axel Montagne; Arthur W Toga; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

Review 10.  Brain imaging of locomotion in neurological conditions.

Authors:  Gilles Allali; Helena M Blumen; Hervé Devanne; Elvira Pirondini; Arnaud Delval; Dimitri Van De Ville
Journal:  Neurophysiol Clin       Date:  2018-10-25       Impact factor: 3.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.